ArticleOncogenesis2020
LIMK2 promotes the metastatic progression of triple-negative breast cancer by activating SRPK1.
Parmanand Malvi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
29 papers cite it
this paperpooled itcites it